Topic: Pharmaceutical

Cardinal Health (NYSE:CAH) announced today that the FDA approved its Lymphoseek injection for pediatric use. […]

Neurodon announced today that it initiated studies to prepare an FDA Investigational New Drug (IND) […]

Cystic fibrosis drugs are the mainstay of the Vertex Pharmaceuticals portfolio now, but the company […]

Glaukos (NYSE:GKOS) announced today that it entered into a licensing agreement with Intratus over its […]

Genentech announced today that the FDA approved its supplemental biologics license application for the Xolair […]

A Covid-19 antibody cocktail developed by Regeneron Pharmaceuticals and Roche has pivotal clinical trial data […]

Teva Pharmaceuticals announced today that it received European marketing authorization for its Seffalair and BroPair […]

Kindeva Drug Delivery and Cambridge Healthcare Innovations announced a collaboration to commercialize the latter’s dry-powder […]

Long-term stabilization and platelet storage product developer Cellphire Therapeutics announced that it closed a $15 […]

Fresenius Kabi announced that it entered into a U.S. distribution agreement with Corvida Medical for […]

Lyndra Therapeutics announced today that it appointed Abigail Jenkins and Jacqueline Fernandes to executive positions […]

Eliem Therapeutics has exited stealth with $80 million and plans to treat chronic pain, depression, […]

Research published today has highlighted potential growth down the line in the transdermal drug delivery […]

Eyenovia (NSDQ:EYEN) today announced positive results from a study of its microdose array print (MAP) pupil […]

Oramed Pharmaceuticals (NSDQ:ORMP) announced that it reached 25% randomization in the enrollment for its oral […]

Savara (NSDQ:SVRA) announced today that it closed its previously announced public offering with proceeds reaching […]

Takeda Pharmaceutical (NYSE:TAK) announced that it is acquiring Maverick Therapeutics in a deal worth up […]

Merck (NYSE:MRK) today announced positive results from a Phase 1 study of its subdermal drug-eluting implant […]

Becton Dickinson (NYSE:BDX) announced today that it acquired smart medication device developer GSL solutions for an […]

Vividion Therapeutics has technology that finds ways to hit promising disease targets that were previously […]

Acorda Therapeutics (NSDQ:ACOR) announced today that its chief of business operations, David Lawrence, is resigning from […]

ForDoz Pharma announced today that it entered into an agreement with LipoMedix to manufacture its […]

Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that they received conditional authorization from European regulators. The […]

Deep Genomics is wasting no time. Two weeks after hiring a new chief business officer […]

Pfizer (NYSE:PFE) and its partner BioNTech (NSDQ:BNTX) announced that they will submit a request today with […]

Vibalogics announced that it initiated the first phase of its planned $150 million investment in a […]

PHILADELPHIA, Oct. 16, 2020 /PRNewswire/ — Enterin, Inc., a privately held, CNS-focused pharmaceutical company based in Philadelphia and developing novel […]